Last month Restructuring Perspectives highlighted crucial issues at the intersection of privacy and distress presented by the Chapter 11 case of 23andMe. Specifically, “Data for Sale” discussed the recent appointment of a...more
What happens to sensitive personal information shared by consumers when the company collecting that information encounters financial distress? That exact issue is currently front and center in the Chapter 11 proceedings of...more
5/28/2025
/ 23andMe ,
Bankruptcy Code ,
Chapter 11 ,
Commercial Bankruptcy ,
Consumer Privacy Rights ,
Cybersecurity ,
Data Privacy ,
Data Selling ,
Liquidity ,
Personally Identifiable Information ,
Pharmaceutical Industry ,
Privacy Laws ,
Sensitive Personal Information